<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/40A7BFF7-E338-48CC-87CE-2EC5F45A6B56"><gtr:id>40A7BFF7-E338-48CC-87CE-2EC5F45A6B56</gtr:id><gtr:name>St Mary's Hospital, London</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91427003-DFB6-48F9-848A-32A456E1C00F"><gtr:id>91427003-DFB6-48F9-848A-32A456E1C00F</gtr:id><gtr:name>Royal Free Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:department>Clinical Developmental Sciences</gtr:department><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/40A7BFF7-E338-48CC-87CE-2EC5F45A6B56"><gtr:id>40A7BFF7-E338-48CC-87CE-2EC5F45A6B56</gtr:id><gtr:name>St Mary's Hospital, London</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91427003-DFB6-48F9-848A-32A456E1C00F"><gtr:id>91427003-DFB6-48F9-848A-32A456E1C00F</gtr:id><gtr:name>Royal Free Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/320A95D7-E544-4371-ACAC-D706B4093FD6"><gtr:id>320A95D7-E544-4371-ACAC-D706B4093FD6</gtr:id><gtr:firstName>David Anthony</gtr:firstName><gtr:surname>Price</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2E02E2A4-8446-4C47-A72B-7AAE7EF67A92"><gtr:id>2E02E2A4-8446-4C47-A72B-7AAE7EF67A92</gtr:id><gtr:firstName>Kristin</gtr:firstName><gtr:surname>Ladell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/90141738-E924-42D2-A5E2-B221B3866AFA"><gtr:id>90141738-E924-42D2-A5E2-B221B3866AFA</gtr:id><gtr:firstName>Becca</gtr:firstName><gtr:surname>Asquith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8F97BFAC-A569-48D1-AB4C-2CFC6D3EC9E1"><gtr:id>8F97BFAC-A569-48D1-AB4C-2CFC6D3EC9E1</gtr:id><gtr:firstName>Derek</gtr:firstName><gtr:surname>Macallan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001052"><gtr:id>4BA5EC5A-2F57-42CD-9B81-8D5325BB47E6</gtr:id><gtr:title>How do lymphocyte proliferation and survival contribute to immunological memory in health, ageing and HIV infection?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001052</gtr:grantReference><gtr:abstractText>The immune system protects us from infections by ?remembering? the infections we have encountered in the past to stop them causing harm again. How does the immune system do this? It sets aside families of cells called lymphocytes, each specific for a particular infection. Paradoxically, these cells appear to be short-lived (weeks-months), whereas we know that immune memory lasts years-decades. The immune system must preserve these families of ?memory cells? somehow, but at the same time it must accommodate new families of memory lymphocytes, as new infections are encountered, and also retain sufficient numbers of cells to combat new microbes.

Problems occur when this system of protection fails. Two common situations leading to problems in the immune system are ageing and HIV infection; both affect an increasing proportion of our population. As we age, the immune system becomes less able to combat infections. This results from an imbalance between different families of memory cells. HIV infection damages some immune cells directly, but it also affects all memory cells indirectly, making immune problems worse. We still do not understand how exactly this happens.

This project investigates how long-term immune memory is maintained by measuring the division rate and survival of different families of lymphocytes within the human body. We will assess how many are short-lived, long-lived and very long-lived by applying four different kinds of measurement, three depending on harmless tracers given to track how fast cells divide, and one measuring changing amounts of radioactive carbon naturally found in the body. The project represents a collaboration five different centres: London, Oxford Cardiff, Stockholm and the National Institutes for Health in the USA.

Understanding why the immune system is weaker in the elderly will help us devise ways to prevent this decline and design better vaccination schemes for elderly people. Understanding immune memory in HIV infection will help us think of new ways to help the immune system fight the virus and improve the use of vaccination in people with HIV/AIDS. 

Our results will be made widely available to the general public, through the press, and to those specifically interested, eg. those who wish to ensure they stay healthy as they age and those affected by HIV/AIDS, through specialist interest groups and lay publications.</gtr:abstractText><gtr:technicalSummary>Background
Human T cell memory depends upon maintaining populations of memory lymphocytes cells for many years or decades. When immune memory fails, either gradually, as in immunosensecence (ageing of the immune system), or dramatically, as in HIV/AIDS, the consequences are profound. In both pathologies, lymphocyte populations are characterised by increased proportions of highly-differentiated cells. 
Objectives
Memory T cell populations are highly dynamic with short average life-spans. The balance between the need for long-lived memory and the need for continual remodelling is achieved by a systematic balancing of proliferation and death/phenotype transition across the whole T cell pool. How this balance is achieved without compromising long-term memory remains poorly understood and is the focus of this project. The primary aim of this project is to understand in quantitative terms how long-term T cell memory responses are (i) maintained in health, (ii) impaired in ageing, or (iii) lost in HIV infection.
Methods and experimental design
We will use in vivo isotopic tracer methods to measure the turnover of human T-lymphocyte populations. These methods are now well-developed, but different approaches have different biases: in vivo deuterium-labelled glucose-labelling detects proliferation in short-lived cells (and can be further biased to very-short-lived cells by Annexin V+ sorting), whilst heavy water labelling is biased towards longer-lived cells, and 14C enrichment studies measure the survival of only very long-lived cells. We will exploit these differences by combining measurement modalities (together with Ki-67 labelling, which gives complementary information), making multiple measurements in the same subjects. We will then use multi-compartment mathematical modelling to develop models with the best overall fit for the kinetic properties of, and inter-relationships between, different phenotypically-defined subpopulations (CD4/CD8; naive, effector-memory, central-memory and CD45-revertant memory cells). Models will be developed in young healthy subjects (n=8), then applied to elderly subjects (n=8) and subjects with HIV-infection (treatment naive, n=8) to assess the impact of these pathologies on T-cell kinetics. Further sub-studies of CD57+ (?senescent) cells in the elderly and PD-1+ (? short-lived) cells in HIV infection will allow us to address the specific contribution of these cell-types.
Application
The information obtained will help us better understand human immune homeostasis and develop new strategies for optimising immunity in the elderly and novel immune strategies for HIV.</gtr:technicalSummary><gtr:fund><gtr:end>2015-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>606051</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Transplantation</gtr:department><gtr:description>Use of Tregulatory cells for treatment of IBD</gtr:description><gtr:id>8528B526-1C1E-4C8D-B05A-6EB0509438F9</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>56ddca49ccc792.22168759-1</gtr:outcomeId><gtr:partnerContribution>They lead on the project</gtr:partnerContribution><gtr:piContribution>Use of stable isotopes to track Treg in vivo in clinical studies</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Research Section of Molecular Haematology</gtr:department><gtr:description>Collaboration with KCH London on CLL</gtr:description><gtr:id>1318C85F-5C54-4376-9DEC-FE517A13058D</gtr:id><gtr:impact>Award of two grants from Leukaemia Lymphoma Research</gtr:impact><gtr:outcomeId>oeRdrAve1J9-1</gtr:outcomeId><gtr:partnerContribution>Development of a new project to evaluate the effect of T cell inhibition on in vivo CLL Leukaemic cell turnover</gtr:partnerContribution><gtr:piContribution>Development of a new project to evaluate the effect of T cell inhibition on in vivo CLL Leukaemic cell turnover</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Jenner Institute</gtr:department><gtr:description>Collaboration on Lymphocyte kinetics in HIV</gtr:description><gtr:id>637B5EDB-2AB7-47F9-88A2-C89D5901C958</gtr:id><gtr:impact>Abstract presentation at CROI 2011</gtr:impact><gtr:outcomeId>178CC4A7026-2</gtr:outcomeId><gtr:partnerContribution>Collaboration in data analysis and interpretationCollaboration in data analysis, interpretation and presentationcollaboration on analysis of HIV viral tropismsCollaboration on mathematical modelling of lymphocyte kinetics</gtr:partnerContribution><gtr:piContribution>Clinical studies of turnover of CD4 T cells in HIV</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St Mary's Hospital, London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration on Lymphocyte kinetics in HIV</gtr:description><gtr:id>5A893909-92C3-47CA-8E6F-47AB07573EAE</gtr:id><gtr:impact>Abstract presentation at CROI 2011</gtr:impact><gtr:outcomeId>178CC4A7026-4</gtr:outcomeId><gtr:partnerContribution>Collaboration in data analysis and interpretationCollaboration in data analysis, interpretation and presentationcollaboration on analysis of HIV viral tropismsCollaboration on mathematical modelling of lymphocyte kinetics</gtr:partnerContribution><gtr:piContribution>Clinical studies of turnover of CD4 T cells in HIV</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Jenner Institute</gtr:department><gtr:description>Collaboration on Lymphocyte kinetics in HIV</gtr:description><gtr:id>3E643F0E-07B9-4E5D-8475-DC4EDB7551C6</gtr:id><gtr:impact>Abstract presentation at CROI 2011</gtr:impact><gtr:outcomeId>178CC4A7026-1</gtr:outcomeId><gtr:partnerContribution>Collaboration in data analysis and interpretationCollaboration in data analysis, interpretation and presentationcollaboration on analysis of HIV viral tropismsCollaboration on mathematical modelling of lymphocyte kinetics</gtr:partnerContribution><gtr:piContribution>Clinical studies of turnover of CD4 T cells in HIV</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of Birmingham - Dr Janet Lord</gtr:description><gtr:id>6039CED8-812C-49A6-8406-26BB1421CA3C</gtr:id><gtr:impact>Grant application to MRC</gtr:impact><gtr:outcomeId>Fva3CAMi4AY-1</gtr:outcomeId><gtr:partnerContribution>Expertise in immune effects of ageing</gtr:partnerContribution><gtr:piContribution>Developing new investigations and grant application on granulocyte kinetics</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Free Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration on Lymphocyte kinetics in HIV</gtr:description><gtr:id>3FEB86A9-8602-4CD4-AB8A-289B6EDE727D</gtr:id><gtr:impact>Abstract presentation at CROI 2011</gtr:impact><gtr:outcomeId>178CC4A7026-3</gtr:outcomeId><gtr:partnerContribution>Collaboration in data analysis and interpretationCollaboration in data analysis, interpretation and presentationcollaboration on analysis of HIV viral tropismsCollaboration on mathematical modelling of lymphocyte kinetics</gtr:partnerContribution><gtr:piContribution>Clinical studies of turnover of CD4 T cells in HIV</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Vaccine Research Center (VRC)</gtr:department><gtr:description>NIH</gtr:description><gtr:id>5345DE1B-5D47-488A-A3EC-08E722E760D7</gtr:id><gtr:impact>New proposal currently being drafted</gtr:impact><gtr:outcomeId>6D588395C2D-1</gtr:outcomeId><gtr:partnerContribution>Development of new concepts and new projects. Learning new techniques and skills.</gtr:partnerContribution><gtr:piContribution>New collaboration with Dr R Koup's group at the Vaccine Research Center, at NIH Bethesda was developed in 2009. this builds on work dones as part of this MRC project.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Lunch Club talk for elderly</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>89125EDC-7ECC-41CF-BF45-5F026E370DD7</gtr:id><gtr:impact>about 50 mostly elderly people attended a talk on ageing and the immune system
&amp;quot;Lunch Plus&amp;quot; hosted by New Malden Baptist church, Surrey - 21/5/2012

Approached by several elderly people willing to participate in research</gtr:impact><gtr:outcomeId>PAtTBnSTzWP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50180</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR Project Grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:fundingRef>12064</gtr:fundingRef><gtr:id>58EBD927-4972-414C-B83B-FBB10A008BFF</gtr:id><gtr:outcomeId>eiJnggmFRd4</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>66918</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR project grant</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:fundingRef>12024</gtr:fundingRef><gtr:id>1D2CDF8B-C6AE-4FFA-992E-0EE1D590883C</gtr:id><gtr:outcomeId>ZieWzMVwHbC</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3635000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Catalyst: DPFS/DCS Full PROPOSAL</gtr:description><gtr:end>2021-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3645A774-0DA4-4F20-89E7-0F8F354FD67D</gtr:id><gtr:outcomeId>56ddc90a724272.90002168</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>With Dr Becca Asquith at Imperial College, we have developed approaches to analysis of lymphocyte labelling kinetics.
A publication manuscript has been submitted and is under review.</gtr:description><gtr:id>04B2EF2C-4974-4D72-BA6B-DCA6F8C526ED</gtr:id><gtr:impact>Better understanding of labelling kinetics</gtr:impact><gtr:outcomeId>5460f4020ff7d7.14969158</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Models of Lymphocyte kinetics</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>As a result of this research we have developed new approaches to analysis of lymphocyte kinetics according to chemokine receptor expression. New cell sorting protocls were developed and new approaches to modelling of quantitative data were employed.</gtr:description><gtr:id>2A3FA1B2-BDA6-49FA-9C00-B39AEEF26836</gtr:id><gtr:impact>Still to be published and disseminated</gtr:impact><gtr:outcomeId>3FC1256CCA0</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Analysis of LC kinetics by chemokine analysis</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>As a result of this research we have developed novel models for understanding how CD4+ T cells interact with HIV to cause CD4 cell depletion.</gtr:description><gtr:id>A68EFA8F-6AA8-4F56-A82A-04D2FB518061</gtr:id><gtr:impact>To be published and disseminated</gtr:impact><gtr:outcomeId>751B20F3644</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Model of LC kinetics in HIV</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>620E7D95-954A-490B-B79E-FB226A843944</gtr:id><gtr:title>Protection versus pathology in aviremic and high viral load HIV-2 infection-the pivotal role of immune activation and T-cell kinetics.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26eb95f4f944a87818ca7d604e361952"><gtr:id>26eb95f4f944a87818ca7d604e361952</gtr:id><gtr:otherNames>Hegedus A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5460ef610199b3.61327503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03BA6BD9-C547-4BCA-B935-A1D324C1E1CD</gtr:id><gtr:title>Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/079767d0a4b0c0f8a106945b368e3781"><gtr:id>079767d0a4b0c0f8a106945b368e3781</gtr:id><gtr:otherNames>Laydon DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>585d57ee92a712.38322005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>484871DF-5258-4840-ACB2-E81C93A139F1</gtr:id><gtr:title>Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0d5f79aa7944f2573f6a755739b87e2"><gtr:id>e0d5f79aa7944f2573f6a755739b87e2</gtr:id><gtr:otherNames>Lahoz-Beneytez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>585d696b9abbb0.86213639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B939B5B-893D-43C3-92A5-55A5256CE261</gtr:id><gtr:title>The fate and lifespan of human monocyte subsets in steady state and systemic inflammation.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc8cdc6403a43b891481955eb1042b72"><gtr:id>dc8cdc6403a43b891481955eb1042b72</gtr:id><gtr:otherNames>Patel AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5a2fd398badfc3.55303638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB10C4FF-99D0-4574-91D0-93AE0476D864</gtr:id><gtr:title>Physiologically Based Simulations of Deuterated Glucose for Quantifying Cell Turnover in Humans.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0d5f79aa7944f2573f6a755739b87e2"><gtr:id>e0d5f79aa7944f2573f6a755739b87e2</gtr:id><gtr:otherNames>Lahoz-Beneytez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a2fd78462b888.60108601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B371E0E-A9B6-4A8F-A8E1-166D6C32EC2F</gtr:id><gtr:title>Quantitating lymphocyte homeostasis in vivo in humans using stable isotope tracers.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa75fc47d835a2ecb0db296abd211e72"><gtr:id>aa75fc47d835a2ecb0db296abd211e72</gtr:id><gtr:otherNames>Westera L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5460f25b6f9a53.76268164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>331548BE-69D7-460E-A45B-2975FB5478D9</gtr:id><gtr:title>Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2beb0e5d39626113f74b8a15a597e4d6"><gtr:id>2beb0e5d39626113f74b8a15a597e4d6</gtr:id><gtr:otherNames>Wallace DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>ArGUfyds2QB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59F62DE8-6601-4F2C-935E-D6F6CC544D22</gtr:id><gtr:title>Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.</gtr:title><gtr:parentPublicationTitle>Reviews in medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d4bec89b63675f4ca163786a7f26441"><gtr:id>7d4bec89b63675f4ca163786a7f26441</gtr:id><gtr:otherNames>Nyamweya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1052-9276</gtr:issn><gtr:outcomeId>e1EnuQmW3fh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCDB20D4-8EAB-4088-BFD6-4F81C44E858A</gtr:id><gtr:title>Measurement of proliferation and disappearance of regulatory T cells in human studies using deuterium-labeled glucose.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d303595cecc95b47227c65d510287e"><gtr:id>05d303595cecc95b47227c65d510287e</gtr:id><gtr:otherNames>Vukmanovic-Stejic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>FmeDDRsQc8h</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5A3167B-F4D8-49B8-AA0B-1E48A74D7A51</gtr:id><gtr:title>The efficiency of the human CD8+ T cell response: how should we quantify it, what determines it, and does it matter?</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce12e2f9902881169843b54b0c95de90"><gtr:id>ce12e2f9902881169843b54b0c95de90</gtr:id><gtr:otherNames>Elemans M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>pm_16300_20_22383867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BDA8505-7938-4D7F-8990-C1BB7348884C</gtr:id><gtr:title>Human lymphocyte dynamics and chronic viral infections</gtr:title><gtr:parentPublicationTitle>IMMUNOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65afcdc3afbf9fa922e8760d9b9a85d6"><gtr:id>65afcdc3afbf9fa922e8760d9b9a85d6</gtr:id><gtr:otherNames>Hegedus A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>RPxZwHDkLtx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B6C3C94-9999-4F29-9BA8-1909E721150D</gtr:id><gtr:title>Can non-lytic CD8+ T cells drive HIV-1 escape?</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c5a2690a6f1e86b28f086620dbdb690"><gtr:id>4c5a2690a6f1e86b28f086620dbdb690</gtr:id><gtr:otherNames>Seich Al Basatena NK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_540e175e17522e513</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFFAB7F8-AAE5-4376-93AF-44A58DB2658B</gtr:id><gtr:title>High production rates sustain in vivo levels of PD-1high simian immunodeficiency virus-specific CD8 T cells in the face of rapid clearance.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/833871a2c9f973bae8866fd14b00c736"><gtr:id>833871a2c9f973bae8866fd14b00c736</gtr:id><gtr:otherNames>Petrovas C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_16300_20_23824823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEC6BCD6-BDD2-4FEC-9D43-909ECE828D8C</gtr:id><gtr:title>HIV-1 adaptation to NK cell-mediated immune pressure.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce12e2f9902881169843b54b0c95de90"><gtr:id>ce12e2f9902881169843b54b0c95de90</gtr:id><gtr:otherNames>Elemans M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a2fd372673506.05213966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>196B8FC5-ADEF-45DF-95C5-6C6803AA7339</gtr:id><gtr:title>Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>YkizwLH7bdE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBF7A8B3-9267-4737-A4E1-7FE0D5DDBBF5</gtr:id><gtr:title>Human T Cell Memory: A Dynamic View.</gtr:title><gtr:parentPublicationTitle>Vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cabc70d293c7a4e38f9015aecdd01633"><gtr:id>cabc70d293c7a4e38f9015aecdd01633</gtr:id><gtr:otherNames>Macallan DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2076-393X</gtr:issn><gtr:outcomeId>58c2e20ef13e64.98149878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08968A8E-FEE5-490E-B398-6F33D02CAA46</gtr:id><gtr:title>Reconciling Estimates of Cell Proliferation from Stable Isotope Labeling Experiments.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bab3900531f14960d7de22aaa9753c9"><gtr:id>4bab3900531f14960d7de22aaa9753c9</gtr:id><gtr:otherNames>Ahmed R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>56ddc780b41b88.65014277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D74E54A-9372-4DA4-9472-16DC7C909BE7</gtr:id><gtr:title>Human Stem Cell-like Memory T Cells Are Maintained in a State of Dynamic Flux.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bab3900531f14960d7de22aaa9753c9"><gtr:id>4bab3900531f14960d7de22aaa9753c9</gtr:id><gtr:otherNames>Ahmed R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c2e1cce62ec8.38619791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72FF9149-AB1C-4AD6-BE66-303F69DB4E91</gtr:id><gtr:title>BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot Data.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52b17ee1326803160fc526368a6ef9a6"><gtr:id>52b17ee1326803160fc526368a6ef9a6</gtr:id><gtr:otherNames>Boelen L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>585d522d4b54a7.67843191</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001052</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>